Company Name: Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The company is focused on the development of T-cell therapies designed to treat cancer.

Ticker Symbol: ADAP (NASDAQ)

Company Website: www.adaptimmune.com

Social Media: Adaptimmune Therapeutics  LinkedIn

Headquarters: Oxford, UK